1
|
Višnjić A, Kovačević P, Veličkov A,
Stojanović M and Mladenović S: Head and neck cutaneous melanoma:
5-year survival analysis in a Serbian university center. World J
Surg Oncol. 18(312)2020.PubMed/NCBI View Article : Google Scholar
|
2
|
Heindl LM, Hofmann-Rummelt C, Adler W,
Bosch JJ, Holbach LM, Naumann GO, Kruse FE and Cursiefen C:
Tumor-associated lymphangiogenesis in the development of
conjunctival melanoma. Invest Ophthalmol Vis Sci. 52:7074–7083.
2011.PubMed/NCBI View Article : Google Scholar
|
3
|
Kase S, Osaki M, Honjo S, Adachi H,
Tsujitani S, Kaibara N and Ito H: Expression of cyclo-oxygenase-2
is correlated with high intratumoral microvessel density and low
apoptotic index in human esophageal squamous cell carcinomas.
Virchows Arch. 442:129–135. 2003.PubMed/NCBI View Article : Google Scholar
|
4
|
Pastushenko I, Vermeulen PB, Carapeto FJ,
Van den Eynden G, Rutten A, Ara M, Dirix LY and Van Laere S: Blood
microvessel density, lymphatic microvessel density and lymphatic
invasion in predicting melanoma metastases: Systematic review and
meta-analysis. Br J Dermatol. 170:66–77. 2014.PubMed/NCBI View Article : Google Scholar
|
5
|
Kase S, Kikuchi I and Ishida S: Expression
of VEGF in human conjunctival melanoma analyzed with
immunohistochemistry. Clin Ophthalmol. 12:2363–2367.
2018.PubMed/NCBI View Article : Google Scholar
|
6
|
Palme C, Wanner A, Romano V, Franchi A,
Haas G, Kaye SB and Steger B: Indocyanine green angiographic
assessment of conjunctival melanocytic disorders. Cornea.
40:1519–1524. 2021.PubMed/NCBI View Article : Google Scholar
|
7
|
American Joint Committee on Cancer (AJCC):
AJCC cancer staging manual. Conjunctival melanoma. 8th edition.
Springer, New York, NY, pp795-803, 2017.
|
8
|
Matsuo T, Yamasaki O, Tanaka T, Katsui K
and Waki T: Proton beam therapy followed by pembrolizumab for giant
ocular surface conjunctival malignant melanoma: A case report. Mol
Clin Oncol. 16(12)2022.PubMed/NCBI View Article : Google Scholar
|
9
|
Cekic SP, Kovacevic PT and Krstic MS:
Giant conjunctival melanoma treated with excision and primary
reconstruction using a partial thickness skin graft. Niger J Clin
Pract. 26:1204–1207. 2023.PubMed/NCBI View Article : Google Scholar
|
10
|
Malik KPS, Dadeya S, Gulliani BP and Gupta
VS: Favourable outcome of giant malignant melanoma of the
conjunctiva despite poor prognostic features. Can J Ophthalmol.
38:397–400. 2003.PubMed/NCBI View Article : Google Scholar
|
11
|
Supit T, Pujisriyani Subiyakto, Nugroho T,
Fitrikasari A and Najatullah : Giant conjunctival melanoma in
a paranoid schizophrenic man: A case report. Ann Med Surg (Lond).
62:391–394. 2021.PubMed/NCBI View Article : Google Scholar
|
12
|
Kikuchi I, Kase S, Ishijima K and Ishida
S: Long-term follow-up of conjunctival melanoma treated with
topical interferon alpha-2b eye drops as adjunctive therapy
following surgical resection. Graefes Arch Clin Exp Ophthalmol.
255:2271–2276. 2017.PubMed/NCBI View Article : Google Scholar
|
13
|
Nuessle S, Auw-Haedrich C, Jiang J,
Boehringer D and Reinhard T: Real-life data of adjuvant IFN-α2b and
MMC in conjunctival melanocytic lesions. Graefes Arch Clin Exp
Ophthalmol. 261:1159–1166. 2023.PubMed/NCBI View Article : Google Scholar
|
14
|
Tuomaala S, Toivonen P, Al-Jamal R and
Kivelä T: Prognostic significance of histopathology of primary
conjunctival melanoma in Caucasians. Curr Eye Res. 32:939–952.
2007.PubMed/NCBI View Article : Google Scholar
|